Craig Lustig

🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯 Years of grit & belief led us here 🥹 Endless thanks to Exelixis⁩ for the trust & Dr. Hecht for leading this global win with me! 🎉 ⁦@UPMCHillmanCC⁩ ir.exelixis.com/news-releases/…

Shocking but not surprising. Any Republicans going to condemn this violence? Tell Trump his statements incite violence? I’m not holding my breath. Live Updates: Minnesota Lawmaker Is Assassinated in Act of ‘Targeted Political Violence’ nytimes.com/live/2025/06/1… via @NYTimes

Claudine Isaacs, MD, FRCPC, FASCO of @LombardiCancer was a discussant at this mornings LBA 1008 session at the #ASCO25 meeting.

Join us to review exciting research from the #ASCO25 Annual Meeting. @marshalj23, @benweinbergmd, @mnoel3232, and @ReetuMukherjiMD will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today: bit.ly/4k63Swd

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

#ASCO25 1st practice changing presentation, which has already been our practice since the initial readout for our patients with #BRAFV600E mutant colorectal cancer. More options for our patients.👏🏽 @OncoAlert

Thrilled to announce our new publication: "Rethinking the Rise of Early Onset GI Cancers" @JNCI_Now Spectrum @RueschCenter @marshalj23 @priyanka_kanth @ReetuMukherjiMD @MarionHartley4 @annebchin @CancerMicrobes @BlaesAnneMD @NancyYouMD @GiannakisLab academic.oup.com/jncics/article…

“This phenomenon among young people has sounded an alarm because it’s not going away,” says @marshalj23, director of the @RueschCenter at @LombardiCancer. In the search to find out what’s driving these high cancer rates, researchers like Drs. Alexandrov and Marshall have been exploring how the gut microbiome may influence cancer development. via @EverydayHealth everydayhealth.com/cancer/bad-gut…

It’s a beautiful day for the 8th Annual Ruesch Center Classic golf tournament. This event provides vital support for GI cancer research at @LombardiCancer. We are grateful for our sponsors and players' continued commitment to the Ruesch Center's work.

Today is Dress in Blue Day! The Clinical Research Management Office and Ruesch Center faculty at @LombardiCancer and @MedStarGUH wear blue to raise awareness of colorectal cancer and support the CRC community. #ColorectalCancerAwarenessMonth #DressInBlueDay

Paper is out!!! FDA approved for NRG1 Fusion+ Non-Small Cell #LungCancer and #PancreaticCancer Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer nejm.org/doi/full/10.10… @AliSchram @StephenVLiu @GIcancerDoc @KReissMD @MerusNV @NEJM @MSKCancerCenter @LombardiCancer

“Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal​ cancers with microscopic residual disease.” Research by @ReetuMukherjiMD, Hongkun Wang, @RuthHe12, @mnoel3232, @benweinbergmd, Louis Weiner and @marshalj23 @LombardiCancer @ASCO #GI25. Abstract # TPS850 Board L3

Today, during @CCAlliance #allycon 2024, Project Cure CRC Co-Chairs, @skopetz, @marshalj23, #KatieChudnovsky, @coloncancermike, and #ChristopherLieuMD gathered. Learn more about the work of this incredible CRC research initiative. colorectalcancer.org/research/resea…

The coach in me knows we can win big this November if we work as a team.

Nothing happens without the great Ruesch team!

We look forward to reconnecting with our colleagues from around the world and disseminating exciting research at #ASCO24. Be sure to join us at booth #11015 to see @marshalj23, @RuthHe12, @benweinbergmd, @mnoel3232, and @ReetuMukherjiMD.

Today, on #ClinicalTrialsDay, we recognize the contributions of clinical research professionals in advancing research at @LombardiCancer. The Lombardi Clinical Trials Office provides administrative, nursing, and data management support for cancer treatment clinical trials.

Today @marshalj23 joined physicians, researchers, patients, survivors, caregivers, and legislators on the hill, to discuss stomach cancer and advocate for those impacted by this disease.

Save the Date for the 15th Annual Ruesch Center Symposium- Nov 22-23, 2024! Sign up to receive more information about the agenda and speakers. bit.ly/3QD9KR5 @LombardiCancer @OncLive

ICYMI: PhRMA’s @ScottLaGanga recently received the 2024 Margaret L. Hodges Leadership Award from @LombardiCancer for his leadership in founding the Ruesch Center Golf Tournament, which has raised $1.5 million for gastrointestinal cancer research. lombardi.georgetown.edu/news-release/g…